Wake Network Retains CRO Santé Cannabis to Conduct Clinical Trials in Psilocybin Therapies
Cannabis Law Report
JUNE 16, 2021
We are excited to explore the potential of emergent psychedelic therapies. Wake is currently developing fungus-derived psilocybin and medicinal mushroom products and is making advancements in the engineering of novel psychedelic biologics, while working on proving out their safety through proprietary genetics-based integration therapies.
Let's personalize your content